SUMO-4 activators, as classified in this context, encompass a range of chemicals that indirectly influence the activity of SUMO-4 by modulating related pathways or cellular processes. These activators do not directly bind or modify SUMO-4; instead, they alter the cellular environment or affect key players in the SUMOylation pathway, which in turn can impact SUMO-4's role in the cell. The chemicals listed range from natural compounds like Curcumin, Resveratrol, and Sulforaphane, to synthetic compounds such as Pyr-41 and MG132. These activators work through various mechanisms: some, like Anacardic Acid and Ginkgolic Acid, inhibit histone acetyltransferases, potentially affecting gene expression and consequently SUMOylation processes. Others, such as Pyr-41 and MG132, target ubiquitination and proteasomal pathways, which are closely linked with SUMOylation. The indirect effect of these chemicals on SUMO-4 is rooted in the interconnected nature of cellular signaling and modification pathways.
Compounds like Chloroquine and Lithium demonstrate the broad spectrum of interactions, influencing lysosomal functions and various signaling pathways, respectively. This highlights the complexity of cellular regulation and the potential for diverse chemicals to indirectly modulate specific processes like those mediated by SUMO-4. The use of these activators provides insights into the intricate network of cellular pathways and offers avenues for understanding the regulatory mechanisms involving SUMO-4. Understanding these relationships is crucial in exploring the regulatory roles of SUMOylation in cellular homeostasis and stress response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic Acid inhibits histone acetyltransferase (HAT), which can lead to altered chromatin structure and indirectly influence SUMOylation processes, including those mediated by SUMO-4. | ||||||
(−)Epicatechin | 490-46-0 | sc-205672 sc-205672A | 1 mg 5 mg | $51.00 $138.00 | ||
Ginkgolic Acid, like Anacardic Acid, is a HAT inhibitor. By modulating histone acetylation, it may indirectly affect SUMO-4 activity by altering gene expression. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 is an inhibitor of the ubiquitin-activating enzyme E1. Although it primarily targets ubiquitination, its effects may overlap with SUMOylation processes, potentially affecting SUMO-4. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. By inhibiting proteasomal degradation, it may indirectly affect SUMO-4 mediated processes by stabilizing proteins involved in SUMOylation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an antimalarial drug, affects lysosomal acidity. It may influence SUMO-4 indirectly by altering the degradation pathways that intersect with SUMOylation. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A, a steroidal lactone, is known to inhibit proteasomal activity and could indirectly affect SUMO-4's role in protein stability and stress responses. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a compound in turmeric, has been shown to affect various signaling pathways and could indirectly influence SUMO-4 activity through its broad biological impacts. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenolic compound, is known for its effects on sirtuins and histone deacetylases, potentially affecting SUMO-4 activity indirectly through epigenetic modulation. | ||||||